Clinical trial
Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter…
NCT00003617 · Lymphoma Trials Office, Other · Unknown status
Key facts
| NCT number | NCT00003617 |
|---|---|
| Title | Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach |
| Official title | Protocol for a Randomised Trial of Observation Versus Chlorambucil After Anti-Helicobacter Therapy in Low Grade Gastric Lymphoma |
| Lead sponsor | Lymphoma Trials Office, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug |
| Interventions | chlorambucil, clarithromycin, omeprazole, tinidazole |
| Enrollment | 200 |
| Start date | Mar 1, 1995 |
| First posted | Mar 12, 2004 |
| Last update posted | Sep 20, 2013 |
| Countries | Hong Kong, Poland, South Africa, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: